Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

The Immunomodulary Effects of Systematic Exercise in Older Adults and People with Parkinson's Disease.

Szymura J, Kubica J, Wiecek M, Pera J.

J Clin Med. 2020 Jan 9;9(1). pii: E184. doi: 10.3390/jcm9010184.

2.

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing.

Ostrowska M, Kubica J, Adamski P, Kubica A, Eyileten C, Postula M, Toma A, Hengstenberg C, Siller-Matula JM.

Front Cardiovasc Med. 2019 Dec 3;6:176. doi: 10.3389/fcvm.2019.00176. eCollection 2019. Review.

3.

Diurnal variations in tissue factor and tissue factor pathway inhibitor concentrations in relation to on-treatment platelet reactivity: an analysis of patients with acute myocardial infarction.

Boinska J, Koziński M, Kasprzak M, Ziołkowska K, Dziembowska I, Ziołkowski M, Kubica J, Rość D.

Platelets. 2019 Nov 20:1-7. doi: 10.1080/09537104.2019.1693037. [Epub ahead of print]

PMID:
31744370
4.

Systematic Balance Exercises Influence Cortical Activation and Serum BDNF Levels in Older Adults.

Kubica J, Szymura J, Domagalik A, Golda S, Wiecek M, Fafrowicz M, Marek T, Pera J.

J Clin Med. 2019 Nov 7;8(11). pii: E1910. doi: 10.3390/jcm8111910.

5.

Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?

Pollesello P, Ben Gal T, Bettex D, Cerny V, Comin-Colet J, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Harjola VP, Herpain A, Heringlake M, Heunks L, Husebye T, Ivancan V, Karason K, Kaul S, Kubica J, Mebazaa A, Mølgaard H, Parissis J, Parkhomenko A, Põder P, Pölzl G, Vrtovec B, Yilmaz MB, Papp Z.

J Clin Med. 2019 Nov 1;8(11). pii: E1834. doi: 10.3390/jcm8111834. Review.

6.

ISAR-REACT 5 - What have we learned?

Kubica J, Jaguszewski M.

Cardiol J. 2019;26(5):427-428. doi: 10.5603/CJ.a2019.0090. Epub 2019 Sep 19. No abstract available.

PMID:
31536136
7.

Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Villani R, Navarese EP, Cavallone F, Kubica J, Bellanti F, Facciorusso A, Vendemiale G, Serviddio G.

Mayo Clin Proc Innov Qual Outcomes. 2019 May 5;3(2):131-140. doi: 10.1016/j.mayocpiqo.2019.01.003. eCollection 2019 Jun.

8.

Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society.

Kołtowski Ł, Legutko J, Filipiak KJ, Dziewierz A, Bartuś S, Buszman P, Buszman P, Ciećwierz D, Dąbrowski M, Dobrzycki S, Gil R, Gorący J, Grygier M, Jaguszewski M, Kochman J, Kubica J, Kuliczkowki W, Lodziński P, Ochała A, Reczuch K, Witkowski A, Wojakowski W, Wójcik J, Dudek D.

Cardiol J. 2019;26(1):1-7. doi: 10.5603/CJ.2019.0029. Review. No abstract available.

9.

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor.

Adamski P, Buszko K, Sikora J, Niezgoda P, Fabiszak T, Ostrowska M, Barańska M, Karczmarska-Wódzka A, Navarese EP, Kubica J.

Sci Rep. 2019 Mar 8;9(1):3924. doi: 10.1038/s41598-019-40628-0.

10.

Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.

Kowalewski M, Gozdek M, Raffa GM, Słomka A, Zieliński K, Kubica J, Anisimowicz L, Kowalewski J, Landes U, Kornowski R, Lorusso R, Suwalski P.

J Cardiovasc Med (Hagerstown). 2019 Apr;20(4):226-236. doi: 10.2459/JCM.0000000000000757.

PMID:
30829877
11.

Age-Related 2-Year Mortality After Transcatheter Aortic Valve Replacement: the YOUNG TAVR Registry.

Navarese EP, Andreotti F, Kołodziejczak M, Wanha W, Lauten A, Veulemans V, Frediani L, Kubica J, de Cillis E, Wojakowski W, Ochala A, Zeus T, Bortone A, Buffon A, Jung C, Pestrichella V, Gurbel PA.

Mayo Clin Proc. 2019 Aug;94(8):1457-1466. doi: 10.1016/j.mayocp.2019.01.008. Epub 2019 Feb 27.

PMID:
30824280
12.

Mild therapeutic hypothermia after out-of-hospital cardiac arrest: What does really matter?

Ratajczak J, Łach P, Umińska J, Pstrągowski K, Kasprzak M, Fabiszak T, Navarese EP, Kubica J.

Cardiol J. 2019 Feb 25. doi: 10.5603/CJ.a2019.0023. [Epub ahead of print]

13.

Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest.

Umińska JM, Ratajczak J, Buszko K, Sobczak P, Sroka W, Marszałł MP, Adamski P, Steblovnik K, Noč M, Kubica J.

Cardiol J. 2019 Feb 25. doi: 10.5603/CJ.a2019.0024. [Epub ahead of print]

14.

Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study.

Kubica J, Adamski P, Buszko K, Barańska M, Sikora J, Marszałł MP, Sobczak P, Sikora A, Kuliczkowski W, Fabiszak T, Kubica A, Jilma B, Alexopoulos D, Navarese EP.

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):139-148. doi: 10.1093/ehjcvp/pvz004.

PMID:
30689800
15.

The Methacrylate Adhesive to Double-Lap Shear Joints Made of High-Strength Steel-Experimental Study.

Kałuża M, Hulimka J, Kubica J, Tekieli M.

Materials (Basel). 2019 Jan 1;12(1). pii: E120. doi: 10.3390/ma12010120.

16.

A study of biological and lifestyle factors, including within-subject variation, affecting concentrations of growth differentiation factor 15 in serum.

Krintus M, Braga F, Kozinski M, Borille S, Kubica J, Sypniewska G, Panteghini M.

Clin Chem Lab Med. 2019 Jun 26;57(7):1035-1043. doi: 10.1515/cclm-2018-0908.

PMID:
30471215
17.

METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial.

Sikora J, Niezgoda P, Barańska M, Buszko K, Skibińska N, Sroka W, Pstrągowski K, Siller-Matula J, Bernd J, Gorog D, Navarese EP, Marszałł MP, Kubica J.

Thromb Haemost. 2018 Dec;118(12):2126-2133. doi: 10.1055/s-0038-1675605. Epub 2018 Nov 19.

PMID:
30453344
18.
19.

Safety and efficacy of self-apposing Stentys drug-eluting stent in left main coronary artery PCI: Multicentre LM-STENTYS registry.

Wańha W, Mielczarek M, Smolka G, Roleder T, Jaguszewski M, Ciećwierz D, Tomasiewicz B, Kubler P, Gorol J, Chmielecki M, Bartuś S, Navarese EP, Kasprzak M, Sukiennik A, Kubica J, Lekston A, Hawranek M, Reczuch K, Gruchała M, Ochała A, Wojakowski W.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):574-582. doi: 10.1002/ccd.27876. Epub 2018 Oct 11.

PMID:
30311397
20.

Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review.

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):47-54. doi: 10.1093/ehjcvp/pvy038. Review.

PMID:
30247574
21.

Comparison of temperature measurements in esophagus and urinary bladder in comatose patients after cardiac arrest undergoing mild therapeutic hypothermia.

Umińska JM, Buszko K, Ratajczak J, Łach P, Pstrągowski K, Dąbrowska A, Adamski P, Skonieczny G, Manitius J, Kubica J.

Cardiol J. 2018 Sep 24. doi: 10.5603/CJ.a2018.0115. [Epub ahead of print]

22.

Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations.

Adamski P, Adamska U, Ostrowska M, Navarese EP, Kubica J.

Expert Opin Pharmacother. 2018 Sep;19(13):1415-1425. doi: 10.1080/14656566.2018.1510487. Epub 2018 Aug 22. Review.

PMID:
30132731
23.

Cangrelor for the treatment of patients with Arterial Thrombosis.

Tantry U, Chaudhary R, Kubica J, Bliden K, Gurbel PA.

Expert Opin Pharmacother. 2018 Aug;19(12):1389-1398. doi: 10.1080/14656566.2018.1506767. Epub 2018 Aug 13. Review.

PMID:
30102083
24.

Metabolism of ticagrelor in patients with acute coronary syndromes.

Adamski P, Buszko K, Sikora J, Niezgoda P, Barańska M, Ostrowska M, Paciorek P, Navarese EP, Gorog DA, Kubica J.

Sci Rep. 2018 Aug 6;8(1):11746. doi: 10.1038/s41598-018-29619-9.

25.

Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis.

Navarese EP, Wernly B, Lichtenauer M, Petrescu AM, Kołodziejczak M, Lauten A, Frediani L, Veulemanns V, Wanha W, Wojakowski W, Lesiak M, Ferrante G, Zeus T, Tantry U, Bliden K, Buffon A, Contegiacomo G, Jung C, Kubica J, Pestrichella V, Gurbel PA.

Int J Cardiol. 2018 Oct 15;269:292-297. doi: 10.1016/j.ijcard.2018.07.009. Epub 2018 Jul 3.

PMID:
30045826
26.

Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention.

Navarese EP, Kołodziejczak M, Petrescu A, Wernly B, Lichtenauer M, Lauten A, Buffon A, Wanha W, Pestrichella V, Sardella G, Contegiacomo G, Tantry U, Bliden K, Kubica J, Gurbel PA.

Expert Rev Cardiovasc Ther. 2018 Jun;16(6):419-429. doi: 10.1080/14779072.2018.1474099. Epub 2018 May 23. Review.

PMID:
29737886
27.

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA.

JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525. Review. Erratum in: JAMA. 2018 Oct 2;320(13):1387.

28.

Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpoint.

Kubica J, Adamski P, Paciorek P, Ładny JR, Kalarus Z, Banasiak W, Kochman W, Gorący J, Wożakowska-Kapłon B, Navarese EP, Kleinrok A, Gil R, Lesiak M, Drożdż J, Kubica A, Filipiak KJ, Kaźmierczak J, Goch A, Grajek S, Basiński A, Szarpak Ł, Grześk G, Hoffman P, Wojakowski W, Gąsior Z, Dobrzycki S, Siller-Matula JM, Witkowski A, Kuliczkowski W, Gruchała M, Timler D, Opolski G, Dudek D, Legutko J, Zielińska M, Wójcik J.

Cardiol J. 2018;25(3):291-300. doi: 10.5603/CJ.a2018.0042. Epub 2018 Apr 19. Review.

29.

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study.

Antczak J, Kowalska K, Klimkowicz-Mrowiec A, Wach B, Kasprzyk K, Banach M, Rzeźnicka-Brzegowy K, Kubica J, Słowik A.

Neuropsychiatr Dis Treat. 2018 Mar 13;14:749-755. doi: 10.2147/NDT.S153213. eCollection 2018.

30.

Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.

Wolff G, Navarese EP, Brockmeyer M, Lin Y, Karathanos A, Kołodziejczak M, Kubica J, Polzin A, Zeus T, Westenfeld R, Andreotti F, Kelm M, Schulze V.

Int J Cardiol. 2018 May 1;258:59-67. doi: 10.1016/j.ijcard.2017.12.088. Review. No abstract available.

PMID:
29544957
31.

Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers.

Bartko J, Schoergenhofer C, Schwameis M, Wadowski P, Kubica J, Jilma B, Hobl EL.

J Pharmacol Exp Ther. 2018 May;365(2):430-436. doi: 10.1124/jpet.117.247213. Epub 2018 Mar 14.

PMID:
29540563
32.

Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population.

Krintus M, Kozinski M, Braga F, Kubica J, Sypniewska G, Panteghini M.

Clin Chem Lab Med. 2018 Jun 27;56(7):1161-1168. doi: 10.1515/cclm-2017-1044.

PMID:
29432202
33.

Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.

Kubica J, Adamski P, Buszko K, Kubica A, Kuliczkowski W, Fabiszak T, Jilma B, Alexopoulos D, Paciorek P, Navarese EP.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):152-157. doi: 10.1093/ehjcvp/pvx032.

PMID:
29040445
34.

Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta-analysis.

Gozdek M, Raffa GM, Suwalski P, Kolodziejczak M, Anisimowicz L, Kubica J, Navarese EP, Kowalewski M; SIRIO-TAVI group.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):495-504. doi: 10.1093/ejcts/ezx347.

PMID:
29029105
35.

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.

Adamski P, Sikora J, Laskowska E, Buszko K, Ostrowska M, Umińska JM, Sikora A, Skibińska N, Sobczak P, Adamska U, Rość D, Kubica A, Paciorek P, Marszałł MP, Navarese EP, Gorog DA, Kubica J.

PLoS One. 2017 Oct 12;12(10):e0186013. doi: 10.1371/journal.pone.0186013. eCollection 2017.

36.

Impact of levosimendan on platelet function.

Sikora J, Pstrągowski K, Skibińska N, Sobczak P, Sikora A, Marszałł MP, Fabiszak T, Grześk G, Kubica J.

Thromb Res. 2017 Nov;159:76-81. doi: 10.1016/j.thromres.2017.10.001. Epub 2017 Oct 2. Review.

PMID:
28987709
37.

Erratum to "Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants" [Clin. Biochem. 50 (2017) 599-604].

Krintus M, Kozinski M, Fabiszak T, Kubica J, Panteghini M, Sypniewska G.

Clin Biochem. 2017 Nov;50(16-17):979. doi: 10.1016/j.clinbiochem.2017.07.006. Epub 2017 Aug 17. No abstract available.

PMID:
28738179
38.

The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.

Obońska K, Kasprzak M, Sikora J, Obońska E, Racki K, Goździkiewicz N, Krintus M, Kubica J.

Trials. 2017 Jul 11;18(1):316. doi: 10.1186/s13063-017-2047-8.

39.

Prasugrel in critically ill patients.

Schoergenhofer C, Hobl EL, Staudinger T, Speidl WS, Heinz G, Siller-Matula J, Zauner C, Reiter B, Kubica J, Jilma B.

Thromb Haemost. 2017 Aug 1;117(8):1582-1587. doi: 10.1160/TH17-03-0154. Epub 2017 Jul 6.

40.

Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis.

Kolodziejczak M, Andreotti F, Kowalewski M, Buffon A, Ciccone MM, Parati G, Scicchitano P, Uminska JM, De Servi S, Bliden KP, Kubica J, Bortone A, Crea F, Gurbel P, Navarese EP.

Ann Intern Med. 2017 Jul 18;167(2):103-111. doi: 10.7326/M17-0120. Epub 2017 Jun 27. Review.

PMID:
28632280
41.

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.

Pölzl G, Altenberger J, Baholli L, Beltrán P, Borbély A, Comin-Colet J, Delgado JF, Fedele F, Fontana A, Fruhwald F, Giamouzis G, Giannakoulas G, Garcia-González MJ, Gustafsson F, Kaikkonen K, Kivikko M, Kubica J, von Lewinski D, Löfman I, Malfatto G, Manito N, Martínez-Sellés M, Masip J, Merkely B, Morandi F, Mølgaard H, Oliva F, Pantev E, Papp Z, Perna GP, Pfister R, Piazza V, Bover R, Rangel-Sousa D, Recio-Mayoral A, Reinecke A, Rieth A, Sarapohja T, Schmidt G, Seidel M, Störk S, Vrtovec B, Wikström G, Yerly P, Pollesello P.

Int J Cardiol. 2017 Sep 15;243:389-395. doi: 10.1016/j.ijcard.2017.05.081. Epub 2017 May 23. Review.

42.

High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.

Kozinski M, Krintus M, Kubica J, Sypniewska G.

Crit Rev Clin Lab Sci. 2017 May;54(3):143-172. doi: 10.1080/10408363.2017.1285268. Epub 2017 May 1. Review.

PMID:
28457177
43.

Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.

Adamski P, Ostrowska M, Sikora J, Obońska K, Buszko K, Krintus M, Sypniewska G, Marszałł MP, Koziński M, Kubica J.

BMJ Open. 2017 Apr 26;7(4):e013218. doi: 10.1136/bmjopen-2016-013218.

44.

Anti-aggregation therapy in patients with acute coronary syndrome - recommendations for medical emergency teams. Experts' standpoint.

Kubica J, Adamski P, Paciorek P, Ładny JR, Kalarus Z, Banasiak W, Kochman W, Gorący J, Wożakowska-Kapłon B, Navarese EP, Kleinrok A, Gil R, Lesiak M, Drożdż J, Kubica A, Filipiak KJ, Kaźmierczak J, Goch A, Grajek S, Basiński A, Szarpak Ł, Grześk G, Hoffman P, Wojakowski W, Gąsior Z, Dobrzycki S, Siller-Matula JM, Witkowski A, Kuliczkowski W, Gruchała M, Timler D, Opolski G, Dudek D, Legutko J, Zielińska M, Wójcik J.

Kardiol Pol. 2017;75(4):399-408. doi: 10.5603/KP.a2017.0057. No abstract available.

45.

High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation.

Sukiennik A, Kasprzak M, Mazurek W, Niezgoda P, Bednarczyk Ł, Kubica J.

Postepy Kardiol Interwencyjnej. 2017;13(1):67-71. doi: 10.5114/aic.2017.66189. Epub 2017 Mar 10. No abstract available.

46.

Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants.

Krintus M, Kozinski M, Fabiszak T, Kubica J, Panteghini M, Sypniewska G.

Clin Biochem. 2017 Jul;50(10-11):599-604. doi: 10.1016/j.clinbiochem.2017.03.015. Epub 2017 Mar 18. Erratum in: Clin Biochem. 2017 Nov;50(16-17):979.

PMID:
28322756
47.

Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina. A pharmacokinetic/pharmacodynamic study.

Niezgoda P, Sikora J, Barańska M, Sikora A, Buszko K, Siemińska E, Marszałł MP, Siller-Matula JM, Jilma B, Alexopoulos D, Fabiszak T, Kubica J.

Thromb Haemost. 2017 Apr 3;117(4):718-726. doi: 10.1160/TH16-08-0670. Epub 2017 Feb 16.

PMID:
28203684
48.

Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis.

Navarese EP, Gurbel PA, Andreotti F, Kołodziejczak MM, Palmer SC, Dias S, Buffon A, Kubica J, Kowalewski M, Jadczyk T, Laskiewicz M, Jędrzejek M, Brockmeyer M, Airoldi F, Ruospo M, De Servi S, Wojakowski W, O' Connor C, Strippoli GF.

PLoS One. 2017 Feb 2;12(2):e0168726. doi: 10.1371/journal.pone.0168726. eCollection 2017. Review.

49.

Current controversies in the use of aspirin and ticagrelor for the treatment of thrombotic events.

Myat A, Tantry US, Kubica J, Gurbel PA.

Expert Rev Cardiovasc Ther. 2016 Dec;14(12):1361-1370. Epub 2016 Nov 2. Review.

PMID:
27740874
50.

Impact of lipid markers and high-sensitivity C-reactive protein on the value of the 99th percentile upper reference limit for high-sensitivity cardiac troponin I.

Krintus M, Kozinski M, Fabiszak T, Kuligowska-Prusinska M, Laskowska E, Lennartz L, Nowak-Los L, Kubica J, Sypniewska G.

Clin Chim Acta. 2016 Nov 1;462:193-200. doi: 10.1016/j.cca.2016.09.020. Epub 2016 Sep 28.

PMID:
27693077

Supplemental Content

Loading ...
Support Center